Back to Authors

Link, Brian K.

https://orcid.org/0000-0001-5084-0698

A5083450833 | I126307644

Mayo Clinic

University of Iowa

Citations 299

Development of a Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1921-1923

10.1182/blood-2022-164692

Incidence of Second Primary Malignancies in Lymphoma Survivors: A Prospective Cohort Study in the Modern Treatment Era

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1934-1936

10.1182/blood-2022-165207

A Genome-Wide Association Study (GWAS) of Event-Free Survival (EFS) in Follicular Lymphoma Patients Treated with Front-Line Immunochemotherapy: A Lysa, Iowa/Mayo MER, and FIL Study

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1307-1309

10.1182/blood-2022-167466

Outcomes and Prognostic Factors of Transformed Follicular Lymphoma: An Analysis from the LEO Consortium

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6642-6644

10.1182/blood-2022-157083

Integrative Genomics Identifies a High-Risk Metabolic and TME Depleted Signature That Predicts Early Clinical Failure in DLBCL

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1742-1744

10.1182/blood-2022-159620

Prediction of Early Disease Progression at 24 Months (POD24) Using Pre-Treatment Biopsies from Patients with Follicular Lymphoma (FL) Treated with Immunochemotherapy (IC)

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6426-6427

10.1182/blood-2022-160351

Development and Validation of the advanced-Stage Hodgkin Lymphoma (HL) International Prognostication Index (A-HIPI): A Report from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 760-762

10.1182/blood-2022-164720

Biological Features of a High-Risk Transcriptional Molecular Subtype in Diffuse Large B-Cell Lymphoma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3548-3550

10.1182/blood-2022-170228

FLIPI24: An Improved International Prognostic Model Developed on Early Events in Follicular Lymphoma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2292-2295

10.1182/blood-2022-157194

P010: Inferior Outcomes for Young Adults Treated on Advanced Stage Clinical Trials: Report from the HoLISTIC Consortium

HemaSphere | October 10, 2022 | Volume: 6 | Issue: No issue available | Pages: 5-5

10.1097/01.hs9.0000890608.32200.eb